PINICAL-MRT : Clinical impact protocols in molecular radiotherapy

Development of guidelines to translate knowledge on molecular radiotherapy into clinical practice

Article 56 of the EC Directive 2013/59/EURATOM, detailing the requirements for individual dose planning for radiotherapy patients, is being introduced in all EU states. This applies to molecular radiotherapy (MRT), which involves the use of radiopharmaceuticals in cancer treatment, but there is currently no standardised method to support clinical compliance. A traceable MRT calibration infrastructure for patient-specific doses has been developed as part of the MetroMRT project and the MRTDosimetry project, however, before it can be transferred to the clinic it needs to be extended and staff trained in its use.

dans le cadre du projet MetroMRT et du projet MRTDosimetry toutefois, avant de pouvoir être transféré à la clinique, il doit être prolongé et le personnel formé à son utilisation.

The project will develop guidelines on how to use the protocols and methods developed in MRTdosimetry and establish traceable practices in clinical centres. This will include how to calibrate, order and perform quality control of quantitative imaging instruments used for dosimetry. Training materials will also be developed to support measurement practices. At the end of the project, the establishment of standard practices for MRT will make it easier for the government agencies involved to ensure compliance with regulations and to provide more accurate and targeted treatments to patients.

Partner CRCT Manuel Bardiès

For more information : >>>

Start date: 2020
End date: 2021

This research programme is part of the European call for tenders EURAMET – The European Association of National Metrology Institutes